Applications of proteomics to osteoarthritis, a musculoskeletal disease characterized by aging

Frontiers in Physiology

Volumn 2 DEC, Issue , 2011, Pages

  Mobasheri, Ali ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Musculoskeletal aging; Osteoarthritis; Proteomics

Indexed keywords

EID: 84866279815     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2011.00108     Document Type: Article

References (48)

1. Aigner, T., Rose, J., Martin, J., and Buckwalter, J. (2004). Aging theories of primary osteoarthritis: from epidemiology to molecular biology. Rejuvenation Res. 7, 134-145.
2. Aigner, T., Soeder, S., and Haag, J. (2006). IL-1beta and BMPs - interactive players of cartilage matrix degradation and regeneration. Eur. Cell. Mater. 12, 49-56.
3. Aigner, T., Vornehm, S. I., Zeiler, G., Dudhia, J., von der Mark, K., and Bayliss, M. T. (1997). Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage. Arthritis Rheum. (Munch.) 40, 562-569.
4. Archer, C. W., and Francis-West, P. (2003). The chondrocyte. Int. J. Biochem. Cell Biol. 35, 401-404.
5. Bay-Jensen, A. C., Sondergaard, B. C., Christiansen, C., Karsdal, M. A., Madsen, S. H., and Qvist, P. (2010). Biochemical markers of joint tissue turnover. Assay Drug Dev. Technol. 8, 118-124.
6. Brittberg, M. (1999). Autologous chondrocyte transplantation. Clin. Orthop. Relat. Res. S147-S155.
7. Buckwalter, J. A., and Mankin, H. J. (1998a). Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr. Course Lect. 47, 487-504.
8. Buckwalter, J. A., and Mankin, H. J. (1998b). Articular cartilage: tissue design and chondrocytematrix interactions. Instr. Course Lect. 47, 477-486.
9. Buckwalter, J. A., Mankin, H. J., and Grodzinsky, A. J. (2005). Articular cartilage and osteoarthritis. Instr. Course Lect. 54, 465-480.
10. Cillero-Pastor, B., Ruiz-Romero, C., Carames, B., Lopez-Armada, M. J., and Blanco, F. J. (2010). Proteomic analysis by twodimensional electrophoresis to identify the normal human chondrocyte proteome stimulated by tumor necrosis factor alpha and interleukin-1beta. Arthritis Rheum. (Munch.) 62
11. Clark, A. G., Jordan, J. M., Vilim, V., Renner, J. B., Dragomir, A. D., Luta, G., and Kraus, V. B. (1999). Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. Arthritis Rheum. (Munch.) 42, 2356-2364.
12. Di Paola, R., and Cuzzocrea, S. (2008). Predictivity and sensitivity of animal models of arthritis. Autoimmun. Rev. 8, 73-75.
13. Eyre, D. R. (2004). Collagens and cartilage matrix homeostasis. Clin. Orthop. Relat. Res. S118-S122.
14. Felson, D. T. (2004). An update on the pathogenesis and epidemiology of osteoarthritis. Radiol. Clin. North Am. 42, 1-9.
15. Feng, H., Danfelter, M., Stromqvist, B., and Heinegard, D. (2006). Extracellular matrix in disc degeneration. J. Bone Joint Surg. Am. 88(Suppl. 2), 25-29.
16. Gharbi, M., Deberg, M., and Henrotin, Y. (2011). Application for proteomic techniques in studying osteoarthritis: a review. Front. Physio. 2:90. doi: 10.3389/fphys.2011.00090.
17. Goldring, M. B., and Berenbaum, F. (2004). The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin. Orthop. Relat. Res. S37-S46.
18. Goldring, M. B., and Goldring, S. R. (2007). Osteoarthritis. J. Cell. Physiol. 213, 626-634.
19. Goldring, M. B., and Marcu, K. B. (2009). Cartilage homeostasis in health and rheumatic diseases. Arthritis Res. Ther. 11, 224.
20. Goldring, S. R., and Goldring, M. B. (2004). The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin. Orthop. Relat. Res. S27-S36.
21. Hamerman, D. (1998). Biology of the aging joint. Clin. Geriatr. Med. 14, 417-433.
22. Hardingham, T. E., and Fosang, A. J. (1992). Proteoglycans: many forms and many functions. FASEB J. 6, 861-870.
23. Hunter, D. J., Losina, E., Guermazi, A., Burstein, D., Lassere, M. N., and Kraus, V. (2010). A pathway and approach to biomarker validation and qualification for osteoarthritis clinical trials. Curr. Drug Targets 11, 536-545.
24. Kraus, V. B. (2005). Biomarkers in osteoarthritis. Curr. Opin. Rheumatol. 17, 641-646.
25. Kraus, V. B., Burnett, B., Coindreau, J., Cottrell, S., Eyre, D., Gendreau, M., Gardiner, J., Garnero, P., Hardin, J., Henrotin, Y., Heinegård, D., Ko, A., Lohmander, L. S., Matthews, G., Menetski, J., Moskowitz, R., Persiani, S., Poole, A. R., Rousseau, J. C., Todman, M., and OARSI FDA Osteoarthritis Biomarkers Working Group. (2011). Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthr. Cartil. 19, 515-542.
26. Kuettner, K. E. (1992). Biochemistry of articular cartilage in health and disease. Clin. Biochem. 25, 155-163.
27. Li, H., Yang, H. S., Wu, T. J., Zhang, X. Y., Jiang, W. H., Ma, Q. L., Chen, Y. X., Xu, Y., Li, S., and Hua, Z. C. (2010). Proteomic analysis of earlyresponse to mechanical stress in neonatal rat mandibular condylar chondrocytes.J. Cell. Physiol. 223, 610-622.
28. Loeser, R. F. (2011). Aging and osteoarthritis. Curr. Opin. Rheumatol. 23, 492-496.
29. Lotz, M. K., and Carames, B. (2011). Autophagy and cartilage homeostasis mechanisms in joint health, aging and OA. Nat. Rev. Rheumatol. 7, 579-587.
30. Lotz, M. K., and Kraus, V. B. (2010). New developments in osteoarthritis. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options. Arthritis Res. Ther. 12, 211.
31. Mobasheri, A., and Henrotin, Y. (2010). Identification, validation and qualification of biomarkers for osteoarthritis in humans and companion animals: mission for the next decade. Vet. J. 185, 95-97.
32. Okada, Y., Shinmei, M., Tanaka, O., Naka, K., Kimura, A., Nakanishi, I., Bayliss, M. T., Iwata, K., and Nagase, H. (1992). Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab. Invest. 66, 680-690.
33. Polacek, M., Bruun, J. A., Johansen, O., and Martinez, I. (2010). Differences in the secretome of cartilage explants and cultured chondrocytes unveiled by SILAC technology. J. Orthop. Res. 28, 1040-1049.
34. Qvist, P., Christiansen, C., Karsdal, M. A., Madsen, S. H., Sondergaard, B. C., and Bay-Jensen, A. C. (2010). Application of biochemical markers in development of drugs for treatment of osteoarthritis. Biomarkers 15, 1-19.
35. Rousseau, J. C., and Delmas, P. D. (2007). Biological markers in osteoarthritis. Nat. Clin. Pract. Rheumatol. 3, 346-356.
36. Ruiz-Romero, C., and Blanco, F. J. (2010). Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis. Osteoarthr. Cartil. 18, 500-509.
37. Ruiz-Romero, C., Calamia, V., Carreira, V., Mateos, J., Fernandez, P., and Blanco, F. J. (2010). Strategies to optimize twodimensional gel electrophoresis analysis of the human joint proteome. Talanta 80, 1552-1560.
38. Ruiz-Romero, C., Lopez-Armada, M. J., and Blanco, F. J. (2005). Proteomic characterization of human normal articular chondrocytes: a novel tool for the study of osteoarthritis and other rheumatic diseases. Proteomics 5, 3048-3059.
39. Samuels, J., Krasnokutsky, S., and Abramson, S. B. (2008). Osteoarthritis: a tale of three tissues. Bull. NYU Hosp. Jt. Dis. 66, 244-250.
40. Shane Anderson, A., and Loeser, R. F. (2010). Why is osteoarthritis an agerelated disease? Best Pract. Res. Clin. Rheumatol. 24, 15-26.
41. Stevens, A. L., Wishnok, J. S., Chai, D. H., Grodzinsky, A. J., and Tannenbaum, S. R. (2008). A sodium dodecyl sulfatepolyacrylamide gel electrophoresisliquid chromatography tandem mass spectrometry analysis of bovine cartilage tissue response to mechanical compression injury and the inflammatory cytokines tumor necrosis factor alpha and interleukin-1beta. Arthritis Rheum. (Munch.) 58, 489-500.
42. Tew, S., Redman, S., Kwan, A., Walker, E., Khan, I., Dowthwaite, G., Thomson, B., and Archer, C. W. (2001). Differences in repair responses between immature and mature cartilage. Clin. Orthop. Relat. Res. S142-S152.
43. Williams, F. M. (2009). Biomarkers: in combination they may do better. Arthritis Res. Ther. 11, 130.
44. Wilson, R., Belluoccio, D., Little, C. B., Fosang, A. J., and Bateman, J. F. (2008a). Proteomic characterization of mouse cartilage degradation in vitro. Arthritis Rheum. (Munch.) 58, 3120-3131.
45. Wilson, R., Belluoccio, D., Little, C. B., Fosang, A. J., and Bateman, J. F. (2008b). Proteomic characterization of mouse cartilage degradation in vitro. Arthritis Rheum. (Munch.) 58, 3120-3131.
46. Woolf,A.D.,and Pfleger,B. (2003). Burden of major musculoskeletal conditions. Bull. World Health Organ. 81, 646-656.
47. Wu, J., Liu, W., Bemis, A., Wang, E., Qiu, Y., Morris, E. A., Flannery, C. R., and Yang, Z. (2007). Comparative proteomic characterization of articular cartilage tissue from normal donors and patients with osteoarthritis. Arthritis Rheum. (Munch.) 56, 3675-3684.
48. Zhang, W. B., and Wang, L. (2009). Labelfree quantitative proteome analysis of skeletal tissues under mechanical load. J. Cell. Biochem. 108, 600-611.